Dublin, March 04, 2025 (GLOBE NEWSWIRE) — The “Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-Phase, Solution-Phase, Hybrid), Services, Application (Therapeutics), End User – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The global peptide synthesis market is projected to surpass USD 1.41 billion in 2029 from USD 0.81 billion in 2024, with a significant CAGR of 11.7%.
The peptide synthesis market is driven by several factors such as advancements in technology, increasing research in drug discovery, and the growing demand for personalized medicine. Additionally, the rising prevalence of chronic diseases such as cancer and diabetes is fueling demand for therapeutic peptides in targeted therapies further propelling the growth of the market.
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the peptide synthesis and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
Bachem Holding AG (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), GenScript (China), and CEM Corporation (US) are some of the major players operating in the peptide synthesis market.
Resins and Amino acids accounted for the dominant share in the reagents market
Based on offerings (products & services), products (Consumables and Instruments), consumables (Reagents and Other Consumables), Reagents (Resins, Amino Acids, Coupling Reagents, Dyes and Fluorescent Labelling Reagents, Deprotection Reagents, Cleavage Reagents and Other Reagents), Instruments (Peptide Synthesizers (automated and manual), Chromatography Equipment, Lyophilizers and Others). Resins form the foundation of solid-phase peptide synthesis (SPPS), serving as a stable platform for the stepwise construction of peptide chains. Advancements in resins such as preloaded resins and specialized linkers are likely to impact positively on the market.
Peptide synthesis services dominate the market
Peptide synthesis services dominated the market due to their ability to meet the increasing demand for custom and complex peptides required in drug discovery, therapeutic development, and research applications. Additionally, the rise of personalized medicine and peptide-based vaccines has increased the demand for custom synthesis driving the segmental growth.
Therapeutics segment dominate the application segment
Advancements in peptide synthesis technologies, such as solid-phase peptide synthesis (SPPS) and recombinant DNA methods, has enabled the efficient production of high-purity, cost-effective peptides for vaccine development. The growing focus on personalized immunotherapies and increased investment in peptide-based vaccine research further reinforce their leading position in the market.
North America: The largest share of the peptide synthesis market
North America dominated the peptide synthesis market and is estimated to continue dominance during the forecast period. US leads the North American market, driven by the strong presence of key players like Thermo Fisher Scientific and CEM Corporation, with substantial funding for biomedical research and innovation in peptide-based therapeutics. Europe holds a significant share of the market, with countries like Germany, and UK being major contributors. This dominance attributed to strong R&D activities, collaborations between academic institutions and industry, and a growing focus on personalized medicine and peptide-based drugs.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 564 |
| Forecast Period | 2024-2029 |
| Estimated Market Value (USD) in 2024 | $0.81 Billion |
| Forecasted Market Value (USD) by 2029 | $1.41 Billion |
| Compound Annual Growth Rate | 11.7% |
| Regions Covered | Global |
Market Dynamics
- Drivers
- Advancements in Peptide Therapeutics
- Innovations in Peptide Synthesis Instruments
- Growing Use of Peptides in Diagnostics and Research
- Restraints
- Regulatory Hurdles
- High Cost of Peptide Synthesis and Instruments
- Opportunities
- Adoption of Personalized Medicine
- Strategic Collaborations and Partnerships
- Challenges
- Immunogenicity Issues
- Environmental Concerns
Additionally, gain insights into the following:
- Trends/Disruptions Impacting Customer Business
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem Analysis
- Investment and Funding Scenario
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Key Conferences and Events, 2025-2026
- Regulatory Landscape
- Key Stakeholders and Buying Criteria
- Impact of AI/Generative AI on Peptide Synthesis Market
Companies Profiled in the Report
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- Genscript
- Kaneka Corporation
- Bachem
- Syngene International Limited
- Mesa Labs, Inc.
- Biotage
- CEM Corporation
- Dalton Pharma Services
- Bio-Synthesis Inc.
- CSBio
- Proteogenix
- Innovagen AB
- Biosynth
- Aurigene Pharmaceutical Services Ltd.
- Cordenpharma
- JPT Peptide Technologies
- Purolite
- Biomatik
- CPC Scientific Inc.
- Advanced Chemtech, Inc.
- Ambiopharm Inc.
- Luxembourg Bio Technologies
- Aapptec
- Anygen
- Chempep
- Proteogenix
For more information about this report visit https://www.researchandmarkets.com/r/dh1zw7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
